JPH0415235B2 - - Google Patents
Info
- Publication number
- JPH0415235B2 JPH0415235B2 JP58085143A JP8514383A JPH0415235B2 JP H0415235 B2 JPH0415235 B2 JP H0415235B2 JP 58085143 A JP58085143 A JP 58085143A JP 8514383 A JP8514383 A JP 8514383A JP H0415235 B2 JPH0415235 B2 JP H0415235B2
- Authority
- JP
- Japan
- Prior art keywords
- apd
- diphosphonate
- gel
- hydroxy
- aminopropane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241001465754 Metazoa Species 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 210000001519 tissue Anatomy 0.000 claims description 9
- XQRLCLUYWUNEEH-UHFFFAOYSA-L diphosphonate(2-) Chemical compound [O-]P(=O)OP([O-])=O XQRLCLUYWUNEEH-UHFFFAOYSA-L 0.000 claims description 8
- 239000000606 toothpaste Substances 0.000 claims description 7
- 206010003246 arthritis Diseases 0.000 claims description 5
- 230000002308 calcification Effects 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 4
- 229940034610 toothpaste Drugs 0.000 claims description 4
- 208000006558 Dental Calculus Diseases 0.000 claims description 2
- 239000003937 drug carrier Substances 0.000 claims description 2
- ZPOACTSYEBEHKU-UHFFFAOYSA-H OC(CCN)(P([O-])(=O)[O-])P([O-])(=O)[O-].OC(CCN)(P([O-])(=O)[O-])P(O)(=O)O.[Ca+2].[Ca+2].[Ca+2] Chemical compound OC(CCN)(P([O-])(=O)[O-])P([O-])(=O)[O-].OC(CCN)(P([O-])(=O)[O-])P(O)(=O)O.[Ca+2].[Ca+2].[Ca+2] ZPOACTSYEBEHKU-UHFFFAOYSA-H 0.000 claims 10
- 208000029725 Metabolic bone disease Diseases 0.000 claims 2
- 239000000499 gel Substances 0.000 description 73
- 239000011575 calcium Substances 0.000 description 29
- 229910052791 calcium Inorganic materials 0.000 description 15
- 150000003839 salts Chemical class 0.000 description 14
- 159000000000 sodium salts Chemical class 0.000 description 14
- 159000000007 calcium salts Chemical class 0.000 description 13
- 230000009885 systemic effect Effects 0.000 description 13
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 12
- 239000002002 slurry Substances 0.000 description 11
- 239000013078 crystal Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 238000002347 injection Methods 0.000 description 10
- 239000007924 injection Substances 0.000 description 10
- 239000002244 precipitate Substances 0.000 description 9
- 230000000451 tissue damage Effects 0.000 description 9
- 231100000827 tissue damage Toxicity 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 210000000988 bone and bone Anatomy 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- 239000002537 cosmetic Substances 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 241000700159 Rattus Species 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- WRUUGTRCQOWXEG-UHFFFAOYSA-N pamidronate Chemical compound NCCC(O)(P(O)(O)=O)P(O)(O)=O WRUUGTRCQOWXEG-UHFFFAOYSA-N 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000001506 calcium phosphate Substances 0.000 description 4
- 229910000389 calcium phosphate Inorganic materials 0.000 description 4
- 235000011010 calcium phosphates Nutrition 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 4
- 238000010254 subcutaneous injection Methods 0.000 description 4
- 239000007929 subcutaneous injection Substances 0.000 description 4
- 238000007910 systemic administration Methods 0.000 description 4
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 4
- -1 Methylene hydroxy diphosphonate Chemical compound 0.000 description 3
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical class [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 210000002683 foot Anatomy 0.000 description 3
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 229940102859 methylene diphosphonate Drugs 0.000 description 3
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 239000012266 salt solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000013268 sustained release Methods 0.000 description 3
- 239000012730 sustained-release form Substances 0.000 description 3
- 230000036269 ulceration Effects 0.000 description 3
- 208000002679 Alveolar Bone Loss Diseases 0.000 description 2
- 208000004434 Calcinosis Diseases 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 238000011887 Necropsy Methods 0.000 description 2
- HWZUDASOMGNLSM-UHFFFAOYSA-N O=P1OCOP(=O)O1 Chemical compound O=P1OCOP(=O)O1 HWZUDASOMGNLSM-UHFFFAOYSA-N 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000002917 arthritic effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 239000002738 chelating agent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000020477 pH reduction Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 210000004872 soft tissue Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- XGYCHIPEPHYUIH-UHFFFAOYSA-N 2-mdp Chemical compound C=1C=CC=CC=1C(O)(C(CN)C)C1=CC=CC=C1 XGYCHIPEPHYUIH-UHFFFAOYSA-N 0.000 description 1
- 208000021959 Abnormal metabolism Diseases 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- DPYZUSDYVFKGKL-UHFFFAOYSA-N C=C.OOP(=O)OP(O)=O Chemical compound C=C.OOP(=O)OP(O)=O DPYZUSDYVFKGKL-UHFFFAOYSA-N 0.000 description 1
- VZWXLOKQWOEIBY-UHFFFAOYSA-N CCN.OP(=O)OP(O)=O Chemical compound CCN.OP(=O)OP(O)=O VZWXLOKQWOEIBY-UHFFFAOYSA-N 0.000 description 1
- FPXLKVLNXFUYQU-UHFFFAOYSA-N CCO.OP(=O)OP(O)=O Chemical compound CCO.OP(=O)OP(O)=O FPXLKVLNXFUYQU-UHFFFAOYSA-N 0.000 description 1
- WMTIOGUVKBSEOW-UHFFFAOYSA-N ClC1(Cl)OP(=O)OP(=O)O1 Chemical compound ClC1(Cl)OP(=O)OP(=O)O1 WMTIOGUVKBSEOW-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 208000009386 Experimental Arthritis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- RKQYCDGIGWDXBY-UHFFFAOYSA-L P(=O)(OO)OP(=O)[O-].C=C.[Na+].[Na+].OOP(=O)OP(=O)[O-] Chemical compound P(=O)(OO)OP(=O)[O-].C=C.[Na+].[Na+].OOP(=O)OP(=O)[O-] RKQYCDGIGWDXBY-UHFFFAOYSA-L 0.000 description 1
- YCUJRYVUXDGOPW-UHFFFAOYSA-N P1(=O)OC(Cl)OP(O1)=O Chemical compound P1(=O)OC(Cl)OP(O1)=O YCUJRYVUXDGOPW-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 238000011888 autopsy Methods 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- OMAAXMJMHFXYFY-UHFFFAOYSA-L calcium trioxidophosphanium Chemical compound [Ca+2].[O-]P([O-])=O OMAAXMJMHFXYFY-UHFFFAOYSA-L 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- QBAJVTLVTLSJAG-UHFFFAOYSA-J dicalcium;3-amino-1,1-diphosphonatopropan-1-ol Chemical class [Ca+2].[Ca+2].NCCC(O)(P([O-])([O-])=O)P([O-])([O-])=O QBAJVTLVTLSJAG-UHFFFAOYSA-J 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000013401 experimental design Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000009036 growth inhibition Effects 0.000 description 1
- 231100000304 hepatotoxicity Toxicity 0.000 description 1
- 238000011540 hip replacement Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 206010023365 keratopathy Diseases 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002324 mouth wash Substances 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 230000002037 soft tissue calcification Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 238000012453 sprague-dawley rat model Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 159000000008 strontium salts Chemical class 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011269 treatment regimen Methods 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more PâC bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
- C07F9/3839—Polyphosphonic acids
- C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/55—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/06—Chelate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Description
æè¡åé
æ¬çºæã¯ãçš®ã
ã®æ²»çããã³å粧äžã®é©çšã«äœ¿
çšãããžãã¹ãããŒãã²ã«ã«é¢ããã ããã€ãã®ãžãã¹ãããŒããäŸãã°ããããã
ã·ãšã¿ã³ãžãã¹ãããŒããã¢ãããšã¿ã³ãžãã¹ã
ããŒãããžã¯ããã¡ãã¬ã³ãžãã¹ãããŒããã¡ã
ã¬ã³ãžãã¹ãããŒãããã³ïŒâããããã·âïŒâ
ã¢ãããããã³âïŒïŒïŒâãžãã¹ãããŒãã¯ã«ã«
ã·ãŠã ã«å¯ŸããŠã®è¯å¥œãªãã¬ãŒãå€ã§ãããšç¥ã
ããŠãããåŸã€ãŠããã®æ§ãªååç©ã¯ãäŸãã°ã
æž æµå€çµæç©äžã®ãã«ããŒãšããŠæçšã§ãããã
ããããããååç©ã®ããéèŠãªå®çšæ§ã¯ã«ã«ã·
ãŠã ã®ç°åžžä»£è¬ãç¹åŸŽãšããç æ°ã®æ²»ççšã®è¬å€
çµæç©ã«ãããä»ã®å®çšæ§ã¯æ¯ç³ããã³ãã©ãã¯
ã®ä»çé²æ¢çšã®ç·Žãæ¯ç£šããŸãã¯å£æŽæµå€ãªã©ã®
å粧çšè£œå€ã«ããã è¬å€äžã®é©çšã«ããããžãã¹ãããŒãã®éèŠãª
äžéœåã¯ããžãã¹ãããŒããç®äžæ³šå°æã«çµç¹æ
å·ã®åå ãšãªãããšããããšããç¹ã§ãããä»ã®
äžéœåã¯ãè¡æ¶²äžãžãã¹ãããŒãã®æ¿åºŠã泚å°åŸ
ïŒæéçšåºŠä»¥å ã§ããŒã¯ã«éãã泚å°åŸïŒæé以
å ã§ããŒã¯å€ã®10ïŒ æªæºã§å®å®ãããšããå©ç¹ã§
ããããã®çµæãå€ãã®ãžãã¹ãããŒãã¯ãã®ã
ãªãã®éãèèã«ãã€ãŠåžåãããããããã¯è
èã«ãã€ãŠææ³ããããåŸã€ãŠãååç©ã®æå©ïŒ
æ害æ¯ã¯ææããã»ã©å¥œé©ã§ã¯ãªãã ç¹å®ã®äžæº¶æ§ã®ïŒâããããã·âïŒâã¢ããã
ããã³âïŒïŒïŒâãžãã¹ãã³é žã«ã«ã·ãŠã å¡©ïŒä»¥
åŸãCa3ïŒAPDïŒ2ãšç¥ãïŒã¯çŽ5.5ãçŽ10ã®PHã§æ°Ž
ãšãšãã«æ¹æããããšç²æ§ã®æ°Žæ§ã²ã«ã圢æãã
ããšãä»åããã€ããããã«ã¯ããã®ã²ã«ã¯å¯æº¶
æ§ãããªãŠã å¡©ãšéåžžã«é¡äŒŒããè¬å€ç¹æ§ããã
ããçµç¹æå·ã®åå ãšãªãåŸåãåçã«å°ãªããš
ããããšãããã€ããã²ã«ã®å šèº«æŸåºïŒreleaseïŒ
ã¯ãããããã®çµæããããªãŠã å¡©ãšæ¯èŒããŠè
èã«ããAPDã®åžåçãäœããªããå šèº«æŸæ£ã
ããããšããããšãããå€ãã®APDã®æ²»çäžçš
éã«ãããŠå©ç¹ãåŸãããã åŸã€ãŠãæ¬çºæã®ç®çã¯ãäžæº¶æ§ã®APDã«ã«
ã·ãŠã å¡©ã®æ°Žæ§ã²ã«ãæäŸããããšã«ãããæ¬çº
æã®æŽãã«ã®ç®çã¯ãäžæº¶æ§APDã«ã«ã·ãŠã å¡©
ã®æ°Žæ§ã²ã«ãããªãè¬å€ããã³å粧çµæç©ãæäŸ
ããããšã«ãããããã«ãæ¬çºæã®ç®çã¯ãäºå®
äžçµç¹æå·ã®å¯äœçšããªãããšãªãã«ã«ã«ã·ãŠã
çŸæ£ãæ²»çããæ¹æ³ãæäŸããããšã«ããããŸ
ããæ¬çºæã¯ã«ã«ã·ãŠã ãã¬ãŒãå€ã®ãããå šèº«
æŸæ£ãå¿ èŠãšããã«ã«ã·ãŠã çŸæ£ãæ²»çããæ¹æ³
ãæäŸãããã®ã§ããã èæ¯æè¡ ç±³åœç¹èš±ç¬¬3962432å·ïŒ1976幎ïŒæïŒæ¥ä»ïŒæ
现æžã«ã¯ãïŒâããããã·âïŒâã¢ãããããã³
âïŒïŒïŒâãžãã¹ãã³é žïŒAPDïŒãŸãã¯ãã®å¯
溶æ§å¡©ãããªãè¬å€çµæç©ãé瀺ãããŠãããã
ã®çµæç©ã¯æž©è¡åç©ã®äœå ã«é£æº¶æ§ã®ã«ã«ã·ãŠã
å¡©ãç°åžžã«ä»çãŸãã¯æº¶è§£ããããšã«ãã€ãŠçã
ãçŸæ£ãæ²»çããã®ã«æçšã§ãããšé瀺ãããŠã
ããAPDã®äžæº¶æ§å¡©ã¯é瀺ãããŠããªãã P.Gysenããã³G.Heynenã®ãAnal.Chem.
Symp.Ser.1ïŒ1980ïŒïŒBiochem Biol.Appl.Isotaâ
chopheresisïŒã®85ã87è²¢ã«ã¯ãAPDãšïŒåéå°
éã®Ca2+ãšã®çžäºäœçšã®çéæ³³åç
ïŒisotachophereticïŒæž¬å®ãè«ããããŠãããPH
ïŒã§ãAPDã®85ïŒ ãæ²æŸ±ãããã²ã«åœ¢æã¯å ±å
ãããŠããªãã ç±³åœç¹èš±ç¬¬3608067å·ïŒ1971幎ïŒæ21æ¥ä»ïŒæ
现æžã«ã¯ãç·Žãæ¯ç£šãã«Î±ãÏã¢ã«ãã¬ã³ãžãã¹
ãã³é žã®äžæº¶æ§ã«ã«ã·ãŠã ããã°ãã·ãŠã ãäºé
ããã³ã¢ã«ãããŠã å¡©ã䜿çšããããšãé瀺ãã
ãŠãããç²åãµã€ãºãååã«å®ããããäžæº¶æ§å¡©
ç²åã¯è±¡ç質æ©è䟡ã®äœãã¿ããå€ãšããŠäœ¿çšã
ããã çºæã®æŠèŠ æ¬çºæã¯ãCa3ïŒAPDïŒ2ãçŽ0.01ïŒ ãçŽïŒïŒ å«
æããæ°Žæ§ã²ã«ïŒä»¥åŸãã²ã«ãšç§°ãïŒã«é¢ããã
APDã®å¯æº¶æ§å¡©ãšæ¯èŒããŠããã®ã²ã«ã§ã¯ã
APDã®å šèº«æŸæ£ããããããã€APDãæäžãã
ãéšäœã§ã®çµç¹æå·ãèããæžå°ããã æ¬çºæã¯ãç矩ã®é¢ã§ããã®ã²ã«ãããªãè¬å€
ããã³å粧æçµæç©ã«ãããã³ç 人ãŸãã¯äººãã
äœçŽã®æž©è¡åç©ã«ã²ã«ãå šèº«æäžãŸãã¯å±éšé©çš
ããããšãããªãããžãã¹ãããŒãã§éåžžæå©ã«
æ²»çããããšãã§ããçŸæ£ãæ²»çããæ¹è¯æ¹æ³
ã«ãä¿ãã çºæã®å ·äœç説æ æ¬æ现æžã«ããããããªã«ã«ã·ãŠã ãžïŒïŒâã
ãããã·âïŒâã¢ãããããã³âïŒïŒïŒâãžãã¹
ãããŒãïŒããšã¯ãã«ã«ã·ãŠã 察ãžãã¹ãããŒã
ã®ã¢ã«æ¯ãïŒïŒïŒã§ããïŒâããããã·âïŒâã¢
ãããããã³âïŒïŒïŒâãžãã¹ãã³é žã«ã«ã·ãŠã
å¡©ãæå³ããã æ¬çºæã¯Ca3ïŒAPDïŒ2ãçŽ0.01ïŒ ãçŽïŒïŒ ã奜
ãŸããã¯çŽ0.05ïŒ ãçŽ1.0ïŒ ãå«æããæ°Žæ§ã²ã«
ã«é¢ãããã®ã§ãããAPDã®å¯æº¶æ§å¡©ããã³
APDèªèº«ãšæ¯èŒããŠããã®ã²ã«ã§ã¯ã人ããã³
ä»ã®æž©è¡åç©ã«ç®äžæäžãããšããçµç¹æå·ãå
çã«å°ãªããããã«ãæ¬ã²ã«ã¯ãå¯æº¶æ§å¡©ããã³
APDèªèº«ãšæ¯èŒããŠå šèº«æŸåºãããããšããç¹
城ããããããã«ãããããããæ¬ã²ã«ã¯ã
APDã®å¯æº¶æ§å¡©ããã³APDèªèº«ãšåãçç©åŠç
ç¹æ§ãæããããã®ç¬ç¹ã®ç¹æ§çµåãã«ãããæ¬
ã²ã«ã¯ãžãã¹ãããŒãã®å€ãã®è¬å€ããã³å粧æ
çµæç©ã«æ¥µããŠæçšãšãªã€ãŠããã æ¬ã²ã«ã¯ãïŒâããããã·âïŒâã¢ããããã
ã³âïŒïŒïŒâãžãã¹ãã³é žã®å¯æº¶æ§å¡©ã®æº¶æ¶²ãå¯
溶æ§ã«ã«ã·ãŠã å¡©ã®æº¶æ¶²ãšåã«æ··åããã ãã§åŸ
ãããããã®æ§ãªå¯æº¶æ§å¡©ã®å¥œé©ãªäŸãšããŠã¯ã
APDãããªãŠã å¡©ããã³CaCl2ãããã奜ãŸãã
ã¯ãéã¯ååŠéè«éïŒããªãã¡ãCa察APDã®æ¯
ãïŒïŒïŒïŒãããããã¯ãããã«éå°éã®Caã
䜿çšãããã溶液ã®PHã¯æ¹æããããšã«ããçŽ
5.5ãçŽ10ã®å€ã«èª¿æŽããããçœè²ã®æ²æŸ±ã圢æ
ããããã®PHã®ç¯å²å€ã§ã¯ãAPDã«ã«ã·ãŠã å¡©
ã®ååŠéè«ã¯Ca3ïŒAPDïŒ2ã§ã¯ãªãã圢æããã
å¡©ã¯å¯æº¶æ§ã§ãããããããã¯äžæº¶æ§ã§ã²ã«ã圢
æããªããã®ã§ãããã®ããããã§ããã PHã®èª¿æŽåŸãã¹ã©ãªãŒãã²ã«ã«ãªãããããã
ã¯æ°é±éãŸãã¯ãã以äžãããããšãããããã
ããã¹ã©ãªãŒãæ¹æãããšãã¯ãïŒæ¥ãŸãã¯ïŒæ¥
åŸã«ã²ã«ãåŸãããã ã²ã«ã¯ãŸããCa3ïŒAPDïŒ2ãçŽïŒãçŽïŒã®PHã§
溶解ãã次ãã§PHãçŽ5.5ãçŽ10ã®å€ã«äžæãã
ãããšã«ãã€ãŠãåŸããããããPHãäžæãããŠ
åŸãããã¹ã©ãªãŒã¯ãæ¹æã®ïŒæ¥ãŸãã¯ïŒæ¥åŸã²
ã«ã圢æããã æ°ãã«èª¿è£œãããã²ã«ã¯äžè¬ã«ãããã«äžéæ
ïŒãä¹³çœè²ãïŒã§ããããïŒãŸãã¯ïŒé±éã®ãã¡ã«
éæã«ãªãã ã¹ã©ãªãŒäžã®é»è§£è³ªã®æ¿åºŠãé«ããšãCa3
ïŒAPDïŒ2ã®ã²ã«åç¹æ§ã¯æªåœ±é¿ãåãããåŸã€
ãŠãã²ã«åå·¥çšã«å ã ã€ãŠã¹ã©ãªãŒãèžæºæ°Žã§æŽ
æµããããšãæãŸããã§ããããæŽæµã¯ãæ²æŸ±ç©
ãé å¿åé¢ããäžæŸæ¶²ãé€å»ããæ²æŸ±ç©ãèžæºæ°Ž
ã«åæžæ¿ãããããšã«ãã€ãŠè¡ãªããããã 以äžã«ç€ºããããã«ãæ¬çºæã®ã²ã«ã¯è»è³ªçµç¹
ã«æå·ãçããããåŸåãåŸæ¥ã®ãžãã¹ãããŒã
ããèãããäœããæ¬çºæè ã¯ãã®çç±ã«é¢ãã
ç¹å®ã®çè«ã«ææãããããšã¯æããªãããæã
ãã«ãCa3ïŒAPDïŒ2ã§ã¯ã«ã«ã·ãŠã ã«å¯ŸããAPD
ã®èŠªååããã®çµç¹æå·ãåé¿ããã«ååæžå°ã
ããããã«ãã²ã«ã¯å¹æçãªãã®ã§ãããã€
APDã®å¯æº¶æ§å¡©ãšåã骚ã«å¯Ÿãã芪ååããã
ãšããã€ãããã®é©ãã¹ãçµæã¯ãCa3ïŒAPDïŒ2
ã«ãã圢æãããç¬ç¹ã®ã²ã«ã«åºå ãããã®ãšæ
ãããããã®çç±ã§ããã®ã²ã«ã¯çµå£ãå±éšãã
ã³å šèº«æäžçšã®è¬å€ããã³å粧éçµæç©ã«äœ¿çšã
ãã«ç¹ã«é©ããŠããã æ¬çºæã®ã²ã«ã¯ãŸããAPDã®å šèº«æŸåºããã
ããšããããšãããã€ããããã«ããããã®ãžã
ã¹ãããŒãã®èèããã³è èã«å¯Ÿããæ¯æ§ã®åé¡
ãããªãåããããããäŸãã°ãAPDãããªãŠ
ã 塩溶液ã®ç®äžæäžåŸãŸããªããè¡æ¶²æµäžã®è¬å€
ã®æ¿åºŠãé«ããªãã身äœã¯è¬å€ãèèã«èç©ãã
ãããšã«ãã€ãŠãã€éèŠéã®è¬å€ãè èããæã
ã€ããããšã«ãã€ãŠåå¿ã瀺ããããããªããã
ã«ã«ã·ãŠã APDã²ã«ã®ç®äžæ³šå°ã«ããšã¥ããŠã
ã²ã«ã¯æ³šå°éšäœã«çãŸãããã€è¡æ¶²æµäžã«ãã€ã
ãæŸåºããã ãã§ãããåŸã€ãŠãè¡æ¶²æµäžã®è¬å€
æ¿åºŠã¯ãã€ããŠããŸãé«ãã¯ãªãããã®çµæãè
èã«ããåžåããã³è èã«ããæãã€ã¯å¯æº¶æ§ã®
APDãããªãŠã 塩溶液ã®å Žåã«ãããããã¯äœ
ããã²ã«ã¯è£åŒ·äœïŒadjuvantïŒèªçºé¢ç¯çã®åŸ
æŸæ²»ççšã®é¢ç¯å ãŸãã¯ç®äžæ³šå°ã«5/4æçšã§ã
ãããšããŸãããã€ãã ã²ã«ã¯ãŸããžãã¹ãããŒãååç©ã®åŸæŸæ§ãå¿
èŠãšããä»ã®é©çšã«æçšã§ãããäŸãã°ã垯è§è
ç ãæ²»çããããã®çŒãžã®é©çšãæ¯æ§œéªšæ倱ãæ
å°éã«ããããææ¯ã«æ¬¡ãæ¯åãžã®é©çšããŸãã¯
è¡é¢ç¯çœ®æåŸã®é¢ç¯ã湿åžããé©çšãã«ããŒãã«
ããã³åå®®éè£ çœ®ãžã®ã«ã«ã·ãŠã ä»çæé·ã®é²
æ¢ãç®èããã³è»è³ªçµç¹ç³ç°åã®é²æ¢ãããã³ãž
ãã¹ãããŒãã®å±éšé©çšãææããä»ã®æ²»çãã
ãã åŠçæ¡ä»¶ã«ããç°ãªãããCa3ïŒAPDïŒ2ã²ã«ã¯
å šèº«æäžãŸãã¯å±éšé©çšãããã®ãã®ããããã§
ãããå šèº«æäžã®ãããã®åœ¢æ ãæ¬æ现æžã§äœ¿çš
ããã«ã¯é©ããŠãããã²ã«ãã©ããã«çµå£æäžã
ããšãAPDã倧ãã骚ã«ããªãä»çããããšã
ããã€ããçµå£æäžã¯å€ãã®å Žå泚å°ããã奜ãŸ
ãããã»ãã®å°ãã®APDå šèº«æäžéãå¿ èŠãšã
ãç¶æ ã®æ²»çã®ããã«ã¯ç¹ã«é©ããŠãããå®å šã§
ãã€å¹æçãªéã®Ca3ïŒAPDïŒ2ã²ã«ã®å šèº«æäžã«
ãã€ãŠæ²»çããããšãã§ããç¶æ ã®äŸãšããŠã¯ã
é¢ç¯çããã³éªšã®ç°åžžä»£è¬ãç¹åŸŽãšãã骚çŸæ£ã
ãããäžè¬ã«ãã²ã«ã¯ããªãã¹ãããŒãã«ããæ²»
çãå¹æçã§ããçŸæ£æ²»çã®ããã«äœ¿çšããã
ãããã®ãããªçŸæ£ã®è©³çŽ°ãªé瀺ã¯ãç±³åœç¹èš±ç¬¬
3683080å·ïŒ1972幎ïŒæïŒæ¥ä»ïŒæ现æžã§èŠãã
ãšãã§ããïŒãã®é瀺ãæ¬çºæã§åç §ãããã®ãš
ããïŒã ã²ã«ããã®ãŸãŸåã¯é©åœãªè¬å€æ äœãšæ··åããŠ
æäžããããšãã§ããããã®æ§ãªæ äœã®äŸãšããŠ
ã¯ãç³ãèèªé žãæ€ç©æ²¹ãã°ãªã³ãŒã«ãã°ãªã»ãª
ã³çããããåäœæè¬åœ¢æ ã§ã®è¬å€çµæç©ã¯ã
Ca3ïŒAPDïŒ2ãçŽ0.01mgãçŽ40ïœã奜ãŸããã¯çŽ
0.1mgãçŽ750mgãå«æããã奜ãŸããçµå£çšåäœ
æè¬åœ¢æ ã¯ãçŽ10mgãçŽ20ïœã®Ca3ïŒAPDïŒ2ãå«
æããããžãã¹ãããŒãã«ã€ããŠã®å¥œé©ãªåäœæ
è¬åœ¢æ ã®äŸã¯ãç±³åœç¹èš±ç¬¬3683080å·æ现æžã«é
瀺ãããŠããïŒãã®é瀺ããæ¬çºæã§åç §ããã
ã®ãšããïŒã æ¬æ现æžã«ããããå®å šã§ãã€å¹æçãªéããš
ã¯ãæ²»çãããã¹ãç¶æ ãèããæ¹è³ªããã«åå
å€ãããé倧ãªå¯äœçšãåé¿ããã«ååå°ãªãé
ãæå³ãããã²ã«ã¯ããããå šèº«æŸåºã«å ããé
åžžã«äœãæè¬å²åã§å¹æçã§ãããçµç¹ãæå·ã
ãåŸåãäœãããšã«å ãããããé«ãæè¬éãæª
å¯äœçšãªãã«æ¡çšããããšãã§ãããæè¬å²åã¯
çŽ0.01mgïŒKgãçŽ500mgïŒKgã奜ãŸããã¯çŽ0.05
mgïŒKgãçŽ10mgïŒKgãã§ãããæè¬éã¯æ£è ã®Kg
äœéãããã®mgAPDãšããŠè¡šããããã ã²ã«ã¯ãã²ã«èªèº«ãšããŠãŸãã¯ä»ã®æåãšæ··å
ãããã®ãšããŠãçš®ã ã®å±éšçé©çšã«æ¥µããŠé©ã
ãŠãããäŸãšããŠã¯ãåµå·çµç¹ã®ç³ç°åãé²æ¢ã
ãããã®ã²ã«ãå«æµžããåµå·ããããæ¯æ§œéªšæ倱
ãæå°éã«ããããæ¯åã«é©çšããããã«ããã«
éŠæãšæ··åãããã®çããããã²ã«ã®ç¹ã«æãŸã
ãçšéã¯ãç·Žãæ¯ç£šãã«ãããæ¬çºæã®ã²ã«ã«ã
ã䜿çšããã«é©ããç·Žãæ¯ç£šãé åç©ã¯ãç±³åœç¹
蚱第3488419å·æ现æžã«é瀺ãããŠããïŒãã®é
瀺ããæ¬çºæã§åç §ãããã®ãšããïŒãæ¬çºæã®
ç·Žãæ¯ç£šãã¯ãã²ã«ãçŽïŒïŒ ãçŽ99ïŒ å«æããŠãª
ãã äŸ Ca3ïŒAPDïŒ2ã²ã«ã®èª¿è£œ PHçŽ2.5ã®APDã¢ããããªãŠã å¡©ã®0.01M溶液
40mlãCaCl2ã®0.2M溶液0.8mlãšæ··åããã次ã
ã§ãKOHã«ããPHã7.4ãŸã§ãã€ããäžãããã»
ãŒPHïŒã§æ²æŸ±ãçæãå§ãããPHãããã«7.4ãŸ
ã§äžããã«ã€ããŠãæ²æŸ±ç©ã®éãå¢ãããæ²æŸ±ç©
ãé å¿åé¢ããè±ã€ãªã³åèžçæ°ŽçŽ40mlã§ïŒåæŽ
æµãããæçµæŽæµåŸãæ²æŸ±ç©ãè±ã€ãªã³åèžçæ°Ž
ã«åæžæ¿ãããŠå šé25mlãšããããã®Ca3
ïŒAPDïŒ2ã¹ã©ãªãŒã100mläžžåºãã©ã¹ã³ã«ç§»ãã
æ¹æãããçŽïŒæ¥åŸã硬ãä¹³çœè²ã®ã²ã«ãçæã
ããã²ã«ã¯çŽïŒé±éã®ãã¡ã«å šãéæã«ãªã€ãã ã²ã«ãCaããã³ïŒ°ã«ã€ããŠåæããããã®ã²
ã«ã¯ãååŠéè«Ca3ïŒAPDïŒ2ã®APDå¡©ã0.5ïŒ å«æ
ãããã®ãšæãããã äŸ äŸã«èšèŒã®ããã«ãCa3ïŒAPDïŒ2ã調補ãã
æŽæµãããåºåœ¢ç©ãé å¿åé¢ç®¡ããåãåºãã也
ç¥ããã也ç¥ç²æ«ã®è©Šæãè±ã€ãªã³åèžçæ°Žã«ã
PH7.4ã§æžæ¿ãããïŒé±éæ¹æãããã²ã«ã¯å šã
çæããªãã€ãã 也ç¥ç²æ«ã®ä»ã®è©Šæãè±ã€ãªã³åèžçæ°Žã«æžæ¿
ãããŠ0.5ïŒ ã¹ã©ãªãŒãçæãããããã®ã¹ã©ãª
ãŒãHClã§2.5ã®PHãŸã§é žæ§ã«ãããæ²æŸ±ç©ã溶
解ããã次ãã§ãPHãKOHã§7.4ãŸã§äžãããæ²
柱ç©ãçæããããã¯çŽïŒæ¥éæ¹æããã®ã¡ã²ã«
ã«ãªã€ãã Ca3ïŒAPDïŒ2ã®æ¿åºŠã0.05ïŒ ã0.1ïŒ ãïŒïŒ ãã
ã³ïŒïŒ ãšããŠãããããäžèšã®å®éšãããè¿ã
ãããã¹ãŠã®å Žåã«ãã²ã«ãçæããã0.05ïŒ ã²
ã«ã¯ç²æ§ã®æ¶²äœã§ãã€ããä»ã®ã²ã«ã¯ãã¹ãŠç¡¬
ãããããã®ç¡¬ãã¯æ¿åºŠã«ã€ããŠé«ããªã€ãŠã
ãã 也ç¥ç²æ«ã®0.5ïŒ ã¹ã©ãªãŒã«ã€ããŠãäžèšã®å®
éšãããè¿ãããé žæ§ååŸãPHãKOHã§10ãŸã§
äžãããïŒæ¥éæ¹æããåŸãã²ã«ãçæããã 0.5ïŒ ã¹ã©ãªãŒã«ã€ããŠãäžèšå®éšãåã³ãã
è¿ããããé žæ§ååŸãPHã¯ïŒãŸã§ããäžããªãã€
ããã¹ã©ãªãŒãïŒé±éæ¹æãããã²ã«ã¯å šã圢æ
ããªãã€ãã APDã®äžæº¶æ§ããªãŠã ããã°ãã·ãŠã ãäºé
ããã³ã¹ããã³ããŠã å¡©ããã²ã«ã圢æãã¹ãè©Š
ã¿ã«ãäžèšã®æ¹æ³ã䜿çšãããAPDã®ãããäž
溶æ§å¡©ã§ã¯ãã²ã«ãçæããªãã€ãã ã¡ãã¬ã³ããããã·ãžãã¹ãããŒã
ïŒMHDPïŒããšãã¬ã³ããããã·ãžãã¹ãããŒã
ïŒEHDPïŒããšãã¬ã³ã¢ãããžãã¹ãããŒã
ïŒEADPïŒãã¡ãã¬ã³ãžãã¹ãããŒãïŒMDPïŒã
ãã³ã¯ããã¡ãã¬ã³ãžãã¹ãããŒãïŒCl2MDPïŒ
ã®äžæº¶æ§ã«ã«ã·ãŠã å¡©ããã²ã«ã圢æããããšè©Š
ã¿ãããããå¡©ã®ã©ããã²ã«ãçæããªãã€ãã çµç¹æå·ååŸåã®è©äŸ¡ éãçŽ250ïœã®ïŒå¹ã®è¥ãéã®ã¹ãã¬ãŒã°ã»ã
ãŒãªãŒç³»ã©ããïŒHarlanïŒãïŒå¹ãã€ïŒçŸ€ã«é
åãããäžæ¹ã®çŸ€ã«ã¯ãAPDã¢ããããªãŠã å¡©
ïŒ0.34ééïŒ ïŒãäœé100ïœããã0.2ml泚å°ããã
ä»æ¹ã®çŸ€ã«ã¯ãCa3ïŒAPDïŒ2ã²ã«ãšããŠAPDãå
é泚å°ãããå šäœã®æ€æ»è©äŸ¡ã«ãããŠãAPDã
ããªãŠã å¡©ã泚å°ããåç©ã調ã¹ãçµæãå³éŒ è¹
é åã®æ³šå°éšäœã§å€ããªïŒæ倧çŽåŸæ°cmïŒç¡¬ãã
ã€ç§»åäžå¯èœãªè¥å€§éšãèªããããããã®ãããŸ
ãã«é£æ¥ããè ¹éšå¢çã«æ²¿ã€ãç®èã®æœ°çåãã
ã®çŸ€ã®ãã¹ãŠã®åç©ã«èªããããã解åã®çµæã
ãã®ãããŸãã¯ç¡¬ããè²ã®ããããã»ãçç¶ã®ã
ã®ã§ãã€ããæå·ã¯çµç¹äžãžæ·±ã延ã³ãŠãããã
泚å°éšäœãè¶ãããŸã§ã¯ããŸã延ã³ãŠããªãã€
ããCa3ïŒAPDïŒ2ã§æ²»çãããåç©ã¯ãéŒ è¹é å
ã§ã®ç®äžèšåŒµãAPDãããªãŠã å¡©ã§æ²»çããã
åç©ã«èŠããããã®ããã¯éåžžã«å°ãããè ¹éšç®
èè¡šé¢ã§ã®æœ°çã®åœ¢è·¡ãå šããªãã€ãã觊蚺ã«ã
ããšããããã®ãããŸãã¯ããã«ãåããåŸãã
ãã§ãããå§åãå ãããšã€ã¶ããããã§ãã€
ãã解åã®çµæããã®çŸ€ã®åç©ããã®æå·ã¯
APDãããªãŠã å¡©ãåããåç©ãšæ¯èŒããŠå°ã
ããã€é£æ¥ã®æ£åžžãªçµç¹ãã極ããŠè¯ãåºç»ãã
ãŠãããAPDãããªãŠã å¡©ã§ã¯ãAPDã«ã«ã·ãŠ
ã å¡©ã«ããçããæå·ããå šäœçã«å€§å€åºãæå·
ãçãããã®ãšæãããããŸããAPDãããªãŠ
ã å¡©ã§ã¯ãAPDã«ã«ã·ãŠã å¡©ã®å Žåèªããããª
ãã€ã朰çåãç®èè¡šé¢ã«çãããå šäœãšããŠã
ã²ã«ã«ããçããè»ããçµç¹ã®æå·ã¯ãããªãŠã
å¡©ã®çã¢ã«ç®äžæ³šå°ã®ãšãã®1/10ã»ã©ã®ãã³ãã
ã§ãã€ãã çµæ¶æé·é²æ¢è©Šéš ç³ç°åçµç¹ã«å¯ŸããAPDã«ã«ã·ãŠã å¡©ã®èŠªå
åã¯ãçµæ¶æé·é²æ¢è©Šéšã«ãã€ãŠå®èšŒããããã
ã®è©Šéšã¯ããªãã¹ãããŒãã«ã€ããŠãªã³é žã«ã«ã·
ãŠã æ²çãæžå°ãããããã«ãããã®ããã³ã·ã€
ã«ãèšå®ãã¹ãéçºãã骚ã®ãããªç³ç°åçµç¹ã«
察ãããããååç©ã®èŠªååãäºæ³ããããã®ãš
ãªããšç€ºãããããã®è©Šéšã¯ãOral Biol.15å·»
731è²¢ïŒ1970ïŒã«Nancollasçã«ãã€ãŠè©³çŽ°ã«èª¬
æãããŠããïŒãã®é瀺ãæ¬çºæã§åç §ãããã®
ãšããïŒã ãã®è©Šéšã«ãããŠãããããã·ã¢ãã¿ã€ãçš®çµ
æ¶ããã«ã«ã·ãŠã ãã¹ããšãŒãã®èªçºæ²æŸ±ã«é¢ã
ãŠã¯é飜åã§ãããèªç¶çºçæ²æŸ±ã«å¯ŸããŠã¯æºå®
å®ãªã«ã«ã·ãŠã ïŒãã¹ããšãŒã溶液ã«æ·»å ããã
ãã®çš®çµæ¶ã«ãããæ²æŸ±ããã³çµæ¶æé·ãèªçºã
ãããçš®æ¶æ·»å åã«ãè©ŠéšååŠç©è³ªãæºå®å®ãª
CaïŒïŒ°æº¶æ¶²ã«æ·»å ãããçš®çµæ¶ã«ããèªçºãã
ãããããã·ã¢ãã¿ã€ã圢æã«ã€ããŠã®ãããå
åŠç©è³ªã®å¹æã¯ãç³ç°åã«ã€ããŠã®ãããååŠç©
質ã®çäœå å¹æã瀺ããã®ã§ããããšãããã€
ãã ã«ã«ã·ãŠã ãã¹ããšãŒãçµæ¶ãçæãããšãæ°Ž
çŽ ã€ãªã³ã®æŸåºïŒPHå€åïŒãçãããçµæ¶æé·ã®
é床ã¯äžå®ãªPHãç¶æããã«å¿ èŠãªå¡©åºã®æ·»å ã
芳å¯ããããšã«ãã€ãŠç£èŠããããããªãã¹ãã
ãŒãã®äœãæ¿åºŠïŒïŒÃ10-6MïŒã§ã¯ãã«ã«ã·ãŠã
ãã¹ããšãŒãã®åœ¢æã20åé以äžé²æ¢ããããšã
å¯èœã§ãããçµæ¶æé·ã®é²æ¢ã¯ããªãã¹ãããŒã
ãã«ã«ã·ãŠã ãã¹ãããŒãçµæ¶æ žãžåžçããåŸå
ã«ãã€ãŠå·Šå³ããããCa3ïŒAPDïŒ2ã²ã«ããã®è©Š
éšã§APDã®ã¢ããããªãŠã å¡©ïŒå¯æº¶æ§ïŒãšæ¯èŒ
ãããã«ã«ã·ãŠã å¡©ïŒã²ã«ïŒã¯ããããã·ã¢ãã¿
ã€ãçµæ¶æé·ãé²æ¢ããã«ãããªãŠã å¡©ãšåãäœ
å¹æçã§ãã€ãã ã²ã«ã®çç©çåé 14CæšèïŒâã¢ããâïŒâããããã·ãããã³
âïŒïŒïŒâãžãã¹ãããŒãïŒ14CâAPDïŒã®ã«ã«
ã·ãŠã ããã³ãããªãŠã å¡©ãã©ããïŒã¹ãã¬ãŒ
ã°ã»ããŒãªãŒããã€ãŒã«ã¹ã»ãªããŒïŒã«ç®äžæäž
ããŠãããïŒçš®ã®åé ããã³ææ³ãæ¯èŒãããïŒ
mlãããAPDã2.85mgå«æããæäžéçŽ0.5ïœã®
溶液ãŸãã¯ã²ã«ãè¡é åäžã«æ³šå°ãããå矀ã®å
ç©æ°ã¯ïŒå¹ãšããã
çšãããžãã¹ãããŒãã²ã«ã«é¢ããã ããã€ãã®ãžãã¹ãããŒããäŸãã°ããããã
ã·ãšã¿ã³ãžãã¹ãããŒããã¢ãããšã¿ã³ãžãã¹ã
ããŒãããžã¯ããã¡ãã¬ã³ãžãã¹ãããŒããã¡ã
ã¬ã³ãžãã¹ãããŒãããã³ïŒâããããã·âïŒâ
ã¢ãããããã³âïŒïŒïŒâãžãã¹ãããŒãã¯ã«ã«
ã·ãŠã ã«å¯ŸããŠã®è¯å¥œãªãã¬ãŒãå€ã§ãããšç¥ã
ããŠãããåŸã€ãŠããã®æ§ãªååç©ã¯ãäŸãã°ã
æž æµå€çµæç©äžã®ãã«ããŒãšããŠæçšã§ãããã
ããããããååç©ã®ããéèŠãªå®çšæ§ã¯ã«ã«ã·
ãŠã ã®ç°åžžä»£è¬ãç¹åŸŽãšããç æ°ã®æ²»ççšã®è¬å€
çµæç©ã«ãããä»ã®å®çšæ§ã¯æ¯ç³ããã³ãã©ãã¯
ã®ä»çé²æ¢çšã®ç·Žãæ¯ç£šããŸãã¯å£æŽæµå€ãªã©ã®
å粧çšè£œå€ã«ããã è¬å€äžã®é©çšã«ããããžãã¹ãããŒãã®éèŠãª
äžéœåã¯ããžãã¹ãããŒããç®äžæ³šå°æã«çµç¹æ
å·ã®åå ãšãªãããšããããšããç¹ã§ãããä»ã®
äžéœåã¯ãè¡æ¶²äžãžãã¹ãããŒãã®æ¿åºŠã泚å°åŸ
ïŒæéçšåºŠä»¥å ã§ããŒã¯ã«éãã泚å°åŸïŒæé以
å ã§ããŒã¯å€ã®10ïŒ æªæºã§å®å®ãããšããå©ç¹ã§
ããããã®çµæãå€ãã®ãžãã¹ãããŒãã¯ãã®ã
ãªãã®éãèèã«ãã€ãŠåžåãããããããã¯è
èã«ãã€ãŠææ³ããããåŸã€ãŠãååç©ã®æå©ïŒ
æ害æ¯ã¯ææããã»ã©å¥œé©ã§ã¯ãªãã ç¹å®ã®äžæº¶æ§ã®ïŒâããããã·âïŒâã¢ããã
ããã³âïŒïŒïŒâãžãã¹ãã³é žã«ã«ã·ãŠã å¡©ïŒä»¥
åŸãCa3ïŒAPDïŒ2ãšç¥ãïŒã¯çŽ5.5ãçŽ10ã®PHã§æ°Ž
ãšãšãã«æ¹æããããšç²æ§ã®æ°Žæ§ã²ã«ã圢æãã
ããšãä»åããã€ããããã«ã¯ããã®ã²ã«ã¯å¯æº¶
æ§ãããªãŠã å¡©ãšéåžžã«é¡äŒŒããè¬å€ç¹æ§ããã
ããçµç¹æå·ã®åå ãšãªãåŸåãåçã«å°ãªããš
ããããšãããã€ããã²ã«ã®å šèº«æŸåºïŒreleaseïŒ
ã¯ãããããã®çµæããããªãŠã å¡©ãšæ¯èŒããŠè
èã«ããAPDã®åžåçãäœããªããå šèº«æŸæ£ã
ããããšããããšãããå€ãã®APDã®æ²»çäžçš
éã«ãããŠå©ç¹ãåŸãããã åŸã€ãŠãæ¬çºæã®ç®çã¯ãäžæº¶æ§ã®APDã«ã«
ã·ãŠã å¡©ã®æ°Žæ§ã²ã«ãæäŸããããšã«ãããæ¬çº
æã®æŽãã«ã®ç®çã¯ãäžæº¶æ§APDã«ã«ã·ãŠã å¡©
ã®æ°Žæ§ã²ã«ãããªãè¬å€ããã³å粧çµæç©ãæäŸ
ããããšã«ãããããã«ãæ¬çºæã®ç®çã¯ãäºå®
äžçµç¹æå·ã®å¯äœçšããªãããšãªãã«ã«ã«ã·ãŠã
çŸæ£ãæ²»çããæ¹æ³ãæäŸããããšã«ããããŸ
ããæ¬çºæã¯ã«ã«ã·ãŠã ãã¬ãŒãå€ã®ãããå šèº«
æŸæ£ãå¿ èŠãšããã«ã«ã·ãŠã çŸæ£ãæ²»çããæ¹æ³
ãæäŸãããã®ã§ããã èæ¯æè¡ ç±³åœç¹èš±ç¬¬3962432å·ïŒ1976幎ïŒæïŒæ¥ä»ïŒæ
现æžã«ã¯ãïŒâããããã·âïŒâã¢ãããããã³
âïŒïŒïŒâãžãã¹ãã³é žïŒAPDïŒãŸãã¯ãã®å¯
溶æ§å¡©ãããªãè¬å€çµæç©ãé瀺ãããŠãããã
ã®çµæç©ã¯æž©è¡åç©ã®äœå ã«é£æº¶æ§ã®ã«ã«ã·ãŠã
å¡©ãç°åžžã«ä»çãŸãã¯æº¶è§£ããããšã«ãã€ãŠçã
ãçŸæ£ãæ²»çããã®ã«æçšã§ãããšé瀺ãããŠã
ããAPDã®äžæº¶æ§å¡©ã¯é瀺ãããŠããªãã P.Gysenããã³G.Heynenã®ãAnal.Chem.
Symp.Ser.1ïŒ1980ïŒïŒBiochem Biol.Appl.Isotaâ
chopheresisïŒã®85ã87è²¢ã«ã¯ãAPDãšïŒåéå°
éã®Ca2+ãšã®çžäºäœçšã®çéæ³³åç
ïŒisotachophereticïŒæž¬å®ãè«ããããŠãããPH
ïŒã§ãAPDã®85ïŒ ãæ²æŸ±ãããã²ã«åœ¢æã¯å ±å
ãããŠããªãã ç±³åœç¹èš±ç¬¬3608067å·ïŒ1971幎ïŒæ21æ¥ä»ïŒæ
现æžã«ã¯ãç·Žãæ¯ç£šãã«Î±ãÏã¢ã«ãã¬ã³ãžãã¹
ãã³é žã®äžæº¶æ§ã«ã«ã·ãŠã ããã°ãã·ãŠã ãäºé
ããã³ã¢ã«ãããŠã å¡©ã䜿çšããããšãé瀺ãã
ãŠãããç²åãµã€ãºãååã«å®ããããäžæº¶æ§å¡©
ç²åã¯è±¡ç質æ©è䟡ã®äœãã¿ããå€ãšããŠäœ¿çšã
ããã çºæã®æŠèŠ æ¬çºæã¯ãCa3ïŒAPDïŒ2ãçŽ0.01ïŒ ãçŽïŒïŒ å«
æããæ°Žæ§ã²ã«ïŒä»¥åŸãã²ã«ãšç§°ãïŒã«é¢ããã
APDã®å¯æº¶æ§å¡©ãšæ¯èŒããŠããã®ã²ã«ã§ã¯ã
APDã®å šèº«æŸæ£ããããããã€APDãæäžãã
ãéšäœã§ã®çµç¹æå·ãèããæžå°ããã æ¬çºæã¯ãç矩ã®é¢ã§ããã®ã²ã«ãããªãè¬å€
ããã³å粧æçµæç©ã«ãããã³ç 人ãŸãã¯äººãã
äœçŽã®æž©è¡åç©ã«ã²ã«ãå šèº«æäžãŸãã¯å±éšé©çš
ããããšãããªãããžãã¹ãããŒãã§éåžžæå©ã«
æ²»çããããšãã§ããçŸæ£ãæ²»çããæ¹è¯æ¹æ³
ã«ãä¿ãã çºæã®å ·äœç説æ æ¬æ现æžã«ããããããªã«ã«ã·ãŠã ãžïŒïŒâã
ãããã·âïŒâã¢ãããããã³âïŒïŒïŒâãžãã¹
ãããŒãïŒããšã¯ãã«ã«ã·ãŠã 察ãžãã¹ãããŒã
ã®ã¢ã«æ¯ãïŒïŒïŒã§ããïŒâããããã·âïŒâã¢
ãããããã³âïŒïŒïŒâãžãã¹ãã³é žã«ã«ã·ãŠã
å¡©ãæå³ããã æ¬çºæã¯Ca3ïŒAPDïŒ2ãçŽ0.01ïŒ ãçŽïŒïŒ ã奜
ãŸããã¯çŽ0.05ïŒ ãçŽ1.0ïŒ ãå«æããæ°Žæ§ã²ã«
ã«é¢ãããã®ã§ãããAPDã®å¯æº¶æ§å¡©ããã³
APDèªèº«ãšæ¯èŒããŠããã®ã²ã«ã§ã¯ã人ããã³
ä»ã®æž©è¡åç©ã«ç®äžæäžãããšããçµç¹æå·ãå
çã«å°ãªããããã«ãæ¬ã²ã«ã¯ãå¯æº¶æ§å¡©ããã³
APDèªèº«ãšæ¯èŒããŠå šèº«æŸåºãããããšããç¹
城ããããããã«ãããããããæ¬ã²ã«ã¯ã
APDã®å¯æº¶æ§å¡©ããã³APDèªèº«ãšåãçç©åŠç
ç¹æ§ãæããããã®ç¬ç¹ã®ç¹æ§çµåãã«ãããæ¬
ã²ã«ã¯ãžãã¹ãããŒãã®å€ãã®è¬å€ããã³å粧æ
çµæç©ã«æ¥µããŠæçšãšãªã€ãŠããã æ¬ã²ã«ã¯ãïŒâããããã·âïŒâã¢ããããã
ã³âïŒïŒïŒâãžãã¹ãã³é žã®å¯æº¶æ§å¡©ã®æº¶æ¶²ãå¯
溶æ§ã«ã«ã·ãŠã å¡©ã®æº¶æ¶²ãšåã«æ··åããã ãã§åŸ
ãããããã®æ§ãªå¯æº¶æ§å¡©ã®å¥œé©ãªäŸãšããŠã¯ã
APDãããªãŠã å¡©ããã³CaCl2ãããã奜ãŸãã
ã¯ãéã¯ååŠéè«éïŒããªãã¡ãCa察APDã®æ¯
ãïŒïŒïŒïŒãããããã¯ãããã«éå°éã®Caã
䜿çšãããã溶液ã®PHã¯æ¹æããããšã«ããçŽ
5.5ãçŽ10ã®å€ã«èª¿æŽããããçœè²ã®æ²æŸ±ã圢æ
ããããã®PHã®ç¯å²å€ã§ã¯ãAPDã«ã«ã·ãŠã å¡©
ã®ååŠéè«ã¯Ca3ïŒAPDïŒ2ã§ã¯ãªãã圢æããã
å¡©ã¯å¯æº¶æ§ã§ãããããããã¯äžæº¶æ§ã§ã²ã«ã圢
æããªããã®ã§ãããã®ããããã§ããã PHã®èª¿æŽåŸãã¹ã©ãªãŒãã²ã«ã«ãªãããããã
ã¯æ°é±éãŸãã¯ãã以äžãããããšãããããã
ããã¹ã©ãªãŒãæ¹æãããšãã¯ãïŒæ¥ãŸãã¯ïŒæ¥
åŸã«ã²ã«ãåŸãããã ã²ã«ã¯ãŸããCa3ïŒAPDïŒ2ãçŽïŒãçŽïŒã®PHã§
溶解ãã次ãã§PHãçŽ5.5ãçŽ10ã®å€ã«äžæãã
ãããšã«ãã€ãŠãåŸããããããPHãäžæãããŠ
åŸãããã¹ã©ãªãŒã¯ãæ¹æã®ïŒæ¥ãŸãã¯ïŒæ¥åŸã²
ã«ã圢æããã æ°ãã«èª¿è£œãããã²ã«ã¯äžè¬ã«ãããã«äžéæ
ïŒãä¹³çœè²ãïŒã§ããããïŒãŸãã¯ïŒé±éã®ãã¡ã«
éæã«ãªãã ã¹ã©ãªãŒäžã®é»è§£è³ªã®æ¿åºŠãé«ããšãCa3
ïŒAPDïŒ2ã®ã²ã«åç¹æ§ã¯æªåœ±é¿ãåãããåŸã€
ãŠãã²ã«åå·¥çšã«å ã ã€ãŠã¹ã©ãªãŒãèžæºæ°Žã§æŽ
æµããããšãæãŸããã§ããããæŽæµã¯ãæ²æŸ±ç©
ãé å¿åé¢ããäžæŸæ¶²ãé€å»ããæ²æŸ±ç©ãèžæºæ°Ž
ã«åæžæ¿ãããããšã«ãã€ãŠè¡ãªããããã 以äžã«ç€ºããããã«ãæ¬çºæã®ã²ã«ã¯è»è³ªçµç¹
ã«æå·ãçããããåŸåãåŸæ¥ã®ãžãã¹ãããŒã
ããèãããäœããæ¬çºæè ã¯ãã®çç±ã«é¢ãã
ç¹å®ã®çè«ã«ææãããããšã¯æããªãããæã
ãã«ãCa3ïŒAPDïŒ2ã§ã¯ã«ã«ã·ãŠã ã«å¯ŸããAPD
ã®èŠªååããã®çµç¹æå·ãåé¿ããã«ååæžå°ã
ããããã«ãã²ã«ã¯å¹æçãªãã®ã§ãããã€
APDã®å¯æº¶æ§å¡©ãšåã骚ã«å¯Ÿãã芪ååããã
ãšããã€ãããã®é©ãã¹ãçµæã¯ãCa3ïŒAPDïŒ2
ã«ãã圢æãããç¬ç¹ã®ã²ã«ã«åºå ãããã®ãšæ
ãããããã®çç±ã§ããã®ã²ã«ã¯çµå£ãå±éšãã
ã³å šèº«æäžçšã®è¬å€ããã³å粧éçµæç©ã«äœ¿çšã
ãã«ç¹ã«é©ããŠããã æ¬çºæã®ã²ã«ã¯ãŸããAPDã®å šèº«æŸåºããã
ããšããããšãããã€ããããã«ããããã®ãžã
ã¹ãããŒãã®èèããã³è èã«å¯Ÿããæ¯æ§ã®åé¡
ãããªãåããããããäŸãã°ãAPDãããªãŠ
ã 塩溶液ã®ç®äžæäžåŸãŸããªããè¡æ¶²æµäžã®è¬å€
ã®æ¿åºŠãé«ããªãã身äœã¯è¬å€ãèèã«èç©ãã
ãããšã«ãã€ãŠãã€éèŠéã®è¬å€ãè èããæã
ã€ããããšã«ãã€ãŠåå¿ã瀺ããããããªããã
ã«ã«ã·ãŠã APDã²ã«ã®ç®äžæ³šå°ã«ããšã¥ããŠã
ã²ã«ã¯æ³šå°éšäœã«çãŸãããã€è¡æ¶²æµäžã«ãã€ã
ãæŸåºããã ãã§ãããåŸã€ãŠãè¡æ¶²æµäžã®è¬å€
æ¿åºŠã¯ãã€ããŠããŸãé«ãã¯ãªãããã®çµæãè
èã«ããåžåããã³è èã«ããæãã€ã¯å¯æº¶æ§ã®
APDãããªãŠã 塩溶液ã®å Žåã«ãããããã¯äœ
ããã²ã«ã¯è£åŒ·äœïŒadjuvantïŒèªçºé¢ç¯çã®åŸ
æŸæ²»ççšã®é¢ç¯å ãŸãã¯ç®äžæ³šå°ã«5/4æçšã§ã
ãããšããŸãããã€ãã ã²ã«ã¯ãŸããžãã¹ãããŒãååç©ã®åŸæŸæ§ãå¿
èŠãšããä»ã®é©çšã«æçšã§ãããäŸãã°ã垯è§è
ç ãæ²»çããããã®çŒãžã®é©çšãæ¯æ§œéªšæ倱ãæ
å°éã«ããããææ¯ã«æ¬¡ãæ¯åãžã®é©çšããŸãã¯
è¡é¢ç¯çœ®æåŸã®é¢ç¯ã湿åžããé©çšãã«ããŒãã«
ããã³åå®®éè£ çœ®ãžã®ã«ã«ã·ãŠã ä»çæé·ã®é²
æ¢ãç®èããã³è»è³ªçµç¹ç³ç°åã®é²æ¢ãããã³ãž
ãã¹ãããŒãã®å±éšé©çšãææããä»ã®æ²»çãã
ãã åŠçæ¡ä»¶ã«ããç°ãªãããCa3ïŒAPDïŒ2ã²ã«ã¯
å šèº«æäžãŸãã¯å±éšé©çšãããã®ãã®ããããã§
ãããå šèº«æäžã®ãããã®åœ¢æ ãæ¬æ现æžã§äœ¿çš
ããã«ã¯é©ããŠãããã²ã«ãã©ããã«çµå£æäžã
ããšãAPDã倧ãã骚ã«ããªãä»çããããšã
ããã€ããçµå£æäžã¯å€ãã®å Žå泚å°ããã奜ãŸ
ãããã»ãã®å°ãã®APDå šèº«æäžéãå¿ èŠãšã
ãç¶æ ã®æ²»çã®ããã«ã¯ç¹ã«é©ããŠãããå®å šã§
ãã€å¹æçãªéã®Ca3ïŒAPDïŒ2ã²ã«ã®å šèº«æäžã«
ãã€ãŠæ²»çããããšãã§ããç¶æ ã®äŸãšããŠã¯ã
é¢ç¯çããã³éªšã®ç°åžžä»£è¬ãç¹åŸŽãšãã骚çŸæ£ã
ãããäžè¬ã«ãã²ã«ã¯ããªãã¹ãããŒãã«ããæ²»
çãå¹æçã§ããçŸæ£æ²»çã®ããã«äœ¿çšããã
ãããã®ãããªçŸæ£ã®è©³çŽ°ãªé瀺ã¯ãç±³åœç¹èš±ç¬¬
3683080å·ïŒ1972幎ïŒæïŒæ¥ä»ïŒæ现æžã§èŠãã
ãšãã§ããïŒãã®é瀺ãæ¬çºæã§åç §ãããã®ãš
ããïŒã ã²ã«ããã®ãŸãŸåã¯é©åœãªè¬å€æ äœãšæ··åããŠ
æäžããããšãã§ããããã®æ§ãªæ äœã®äŸãšããŠ
ã¯ãç³ãèèªé žãæ€ç©æ²¹ãã°ãªã³ãŒã«ãã°ãªã»ãª
ã³çããããåäœæè¬åœ¢æ ã§ã®è¬å€çµæç©ã¯ã
Ca3ïŒAPDïŒ2ãçŽ0.01mgãçŽ40ïœã奜ãŸããã¯çŽ
0.1mgãçŽ750mgãå«æããã奜ãŸããçµå£çšåäœ
æè¬åœ¢æ ã¯ãçŽ10mgãçŽ20ïœã®Ca3ïŒAPDïŒ2ãå«
æããããžãã¹ãããŒãã«ã€ããŠã®å¥œé©ãªåäœæ
è¬åœ¢æ ã®äŸã¯ãç±³åœç¹èš±ç¬¬3683080å·æ现æžã«é
瀺ãããŠããïŒãã®é瀺ããæ¬çºæã§åç §ããã
ã®ãšããïŒã æ¬æ现æžã«ããããå®å šã§ãã€å¹æçãªéããš
ã¯ãæ²»çãããã¹ãç¶æ ãèããæ¹è³ªããã«åå
å€ãããé倧ãªå¯äœçšãåé¿ããã«ååå°ãªãé
ãæå³ãããã²ã«ã¯ããããå šèº«æŸåºã«å ããé
åžžã«äœãæè¬å²åã§å¹æçã§ãããçµç¹ãæå·ã
ãåŸåãäœãããšã«å ãããããé«ãæè¬éãæª
å¯äœçšãªãã«æ¡çšããããšãã§ãããæè¬å²åã¯
çŽ0.01mgïŒKgãçŽ500mgïŒKgã奜ãŸããã¯çŽ0.05
mgïŒKgãçŽ10mgïŒKgãã§ãããæè¬éã¯æ£è ã®Kg
äœéãããã®mgAPDãšããŠè¡šããããã ã²ã«ã¯ãã²ã«èªèº«ãšããŠãŸãã¯ä»ã®æåãšæ··å
ãããã®ãšããŠãçš®ã ã®å±éšçé©çšã«æ¥µããŠé©ã
ãŠãããäŸãšããŠã¯ãåµå·çµç¹ã®ç³ç°åãé²æ¢ã
ãããã®ã²ã«ãå«æµžããåµå·ããããæ¯æ§œéªšæ倱
ãæå°éã«ããããæ¯åã«é©çšããããã«ããã«
éŠæãšæ··åãããã®çããããã²ã«ã®ç¹ã«æãŸã
ãçšéã¯ãç·Žãæ¯ç£šãã«ãããæ¬çºæã®ã²ã«ã«ã
ã䜿çšããã«é©ããç·Žãæ¯ç£šãé åç©ã¯ãç±³åœç¹
蚱第3488419å·æ现æžã«é瀺ãããŠããïŒãã®é
瀺ããæ¬çºæã§åç §ãããã®ãšããïŒãæ¬çºæã®
ç·Žãæ¯ç£šãã¯ãã²ã«ãçŽïŒïŒ ãçŽ99ïŒ å«æããŠãª
ãã äŸ Ca3ïŒAPDïŒ2ã²ã«ã®èª¿è£œ PHçŽ2.5ã®APDã¢ããããªãŠã å¡©ã®0.01M溶液
40mlãCaCl2ã®0.2M溶液0.8mlãšæ··åããã次ã
ã§ãKOHã«ããPHã7.4ãŸã§ãã€ããäžãããã»
ãŒPHïŒã§æ²æŸ±ãçæãå§ãããPHãããã«7.4ãŸ
ã§äžããã«ã€ããŠãæ²æŸ±ç©ã®éãå¢ãããæ²æŸ±ç©
ãé å¿åé¢ããè±ã€ãªã³åèžçæ°ŽçŽ40mlã§ïŒåæŽ
æµãããæçµæŽæµåŸãæ²æŸ±ç©ãè±ã€ãªã³åèžçæ°Ž
ã«åæžæ¿ãããŠå šé25mlãšããããã®Ca3
ïŒAPDïŒ2ã¹ã©ãªãŒã100mläžžåºãã©ã¹ã³ã«ç§»ãã
æ¹æãããçŽïŒæ¥åŸã硬ãä¹³çœè²ã®ã²ã«ãçæã
ããã²ã«ã¯çŽïŒé±éã®ãã¡ã«å šãéæã«ãªã€ãã ã²ã«ãCaããã³ïŒ°ã«ã€ããŠåæããããã®ã²
ã«ã¯ãååŠéè«Ca3ïŒAPDïŒ2ã®APDå¡©ã0.5ïŒ å«æ
ãããã®ãšæãããã äŸ äŸã«èšèŒã®ããã«ãCa3ïŒAPDïŒ2ã調補ãã
æŽæµãããåºåœ¢ç©ãé å¿åé¢ç®¡ããåãåºãã也
ç¥ããã也ç¥ç²æ«ã®è©Šæãè±ã€ãªã³åèžçæ°Žã«ã
PH7.4ã§æžæ¿ãããïŒé±éæ¹æãããã²ã«ã¯å šã
çæããªãã€ãã 也ç¥ç²æ«ã®ä»ã®è©Šæãè±ã€ãªã³åèžçæ°Žã«æžæ¿
ãããŠ0.5ïŒ ã¹ã©ãªãŒãçæãããããã®ã¹ã©ãª
ãŒãHClã§2.5ã®PHãŸã§é žæ§ã«ãããæ²æŸ±ç©ã溶
解ããã次ãã§ãPHãKOHã§7.4ãŸã§äžãããæ²
柱ç©ãçæããããã¯çŽïŒæ¥éæ¹æããã®ã¡ã²ã«
ã«ãªã€ãã Ca3ïŒAPDïŒ2ã®æ¿åºŠã0.05ïŒ ã0.1ïŒ ãïŒïŒ ãã
ã³ïŒïŒ ãšããŠãããããäžèšã®å®éšãããè¿ã
ãããã¹ãŠã®å Žåã«ãã²ã«ãçæããã0.05ïŒ ã²
ã«ã¯ç²æ§ã®æ¶²äœã§ãã€ããä»ã®ã²ã«ã¯ãã¹ãŠç¡¬
ãããããã®ç¡¬ãã¯æ¿åºŠã«ã€ããŠé«ããªã€ãŠã
ãã 也ç¥ç²æ«ã®0.5ïŒ ã¹ã©ãªãŒã«ã€ããŠãäžèšã®å®
éšãããè¿ãããé žæ§ååŸãPHãKOHã§10ãŸã§
äžãããïŒæ¥éæ¹æããåŸãã²ã«ãçæããã 0.5ïŒ ã¹ã©ãªãŒã«ã€ããŠãäžèšå®éšãåã³ãã
è¿ããããé žæ§ååŸãPHã¯ïŒãŸã§ããäžããªãã€
ããã¹ã©ãªãŒãïŒé±éæ¹æãããã²ã«ã¯å šã圢æ
ããªãã€ãã APDã®äžæº¶æ§ããªãŠã ããã°ãã·ãŠã ãäºé
ããã³ã¹ããã³ããŠã å¡©ããã²ã«ã圢æãã¹ãè©Š
ã¿ã«ãäžèšã®æ¹æ³ã䜿çšãããAPDã®ãããäž
溶æ§å¡©ã§ã¯ãã²ã«ãçæããªãã€ãã ã¡ãã¬ã³ããããã·ãžãã¹ãããŒã
ïŒMHDPïŒããšãã¬ã³ããããã·ãžãã¹ãããŒã
ïŒEHDPïŒããšãã¬ã³ã¢ãããžãã¹ãããŒã
ïŒEADPïŒãã¡ãã¬ã³ãžãã¹ãããŒãïŒMDPïŒã
ãã³ã¯ããã¡ãã¬ã³ãžãã¹ãããŒãïŒCl2MDPïŒ
ã®äžæº¶æ§ã«ã«ã·ãŠã å¡©ããã²ã«ã圢æããããšè©Š
ã¿ãããããå¡©ã®ã©ããã²ã«ãçæããªãã€ãã çµç¹æå·ååŸåã®è©äŸ¡ éãçŽ250ïœã®ïŒå¹ã®è¥ãéã®ã¹ãã¬ãŒã°ã»ã
ãŒãªãŒç³»ã©ããïŒHarlanïŒãïŒå¹ãã€ïŒçŸ€ã«é
åãããäžæ¹ã®çŸ€ã«ã¯ãAPDã¢ããããªãŠã å¡©
ïŒ0.34ééïŒ ïŒãäœé100ïœããã0.2ml泚å°ããã
ä»æ¹ã®çŸ€ã«ã¯ãCa3ïŒAPDïŒ2ã²ã«ãšããŠAPDãå
é泚å°ãããå šäœã®æ€æ»è©äŸ¡ã«ãããŠãAPDã
ããªãŠã å¡©ã泚å°ããåç©ã調ã¹ãçµæãå³éŒ è¹
é åã®æ³šå°éšäœã§å€ããªïŒæ倧çŽåŸæ°cmïŒç¡¬ãã
ã€ç§»åäžå¯èœãªè¥å€§éšãèªããããããã®ãããŸ
ãã«é£æ¥ããè ¹éšå¢çã«æ²¿ã€ãç®èã®æœ°çåãã
ã®çŸ€ã®ãã¹ãŠã®åç©ã«èªããããã解åã®çµæã
ãã®ãããŸãã¯ç¡¬ããè²ã®ããããã»ãçç¶ã®ã
ã®ã§ãã€ããæå·ã¯çµç¹äžãžæ·±ã延ã³ãŠãããã
泚å°éšäœãè¶ãããŸã§ã¯ããŸã延ã³ãŠããªãã€
ããCa3ïŒAPDïŒ2ã§æ²»çãããåç©ã¯ãéŒ è¹é å
ã§ã®ç®äžèšåŒµãAPDãããªãŠã å¡©ã§æ²»çããã
åç©ã«èŠããããã®ããã¯éåžžã«å°ãããè ¹éšç®
èè¡šé¢ã§ã®æœ°çã®åœ¢è·¡ãå šããªãã€ãã觊蚺ã«ã
ããšããããã®ãããŸãã¯ããã«ãåããåŸãã
ãã§ãããå§åãå ãããšã€ã¶ããããã§ãã€
ãã解åã®çµæããã®çŸ€ã®åç©ããã®æå·ã¯
APDãããªãŠã å¡©ãåããåç©ãšæ¯èŒããŠå°ã
ããã€é£æ¥ã®æ£åžžãªçµç¹ãã極ããŠè¯ãåºç»ãã
ãŠãããAPDãããªãŠã å¡©ã§ã¯ãAPDã«ã«ã·ãŠ
ã å¡©ã«ããçããæå·ããå šäœçã«å€§å€åºãæå·
ãçãããã®ãšæãããããŸããAPDãããªãŠ
ã å¡©ã§ã¯ãAPDã«ã«ã·ãŠã å¡©ã®å Žåèªããããª
ãã€ã朰çåãç®èè¡šé¢ã«çãããå šäœãšããŠã
ã²ã«ã«ããçããè»ããçµç¹ã®æå·ã¯ãããªãŠã
å¡©ã®çã¢ã«ç®äžæ³šå°ã®ãšãã®1/10ã»ã©ã®ãã³ãã
ã§ãã€ãã çµæ¶æé·é²æ¢è©Šéš ç³ç°åçµç¹ã«å¯ŸããAPDã«ã«ã·ãŠã å¡©ã®èŠªå
åã¯ãçµæ¶æé·é²æ¢è©Šéšã«ãã€ãŠå®èšŒããããã
ã®è©Šéšã¯ããªãã¹ãããŒãã«ã€ããŠãªã³é žã«ã«ã·
ãŠã æ²çãæžå°ãããããã«ãããã®ããã³ã·ã€
ã«ãèšå®ãã¹ãéçºãã骚ã®ãããªç³ç°åçµç¹ã«
察ãããããååç©ã®èŠªååãäºæ³ããããã®ãš
ãªããšç€ºãããããã®è©Šéšã¯ãOral Biol.15å·»
731è²¢ïŒ1970ïŒã«Nancollasçã«ãã€ãŠè©³çŽ°ã«èª¬
æãããŠããïŒãã®é瀺ãæ¬çºæã§åç §ãããã®
ãšããïŒã ãã®è©Šéšã«ãããŠãããããã·ã¢ãã¿ã€ãçš®çµ
æ¶ããã«ã«ã·ãŠã ãã¹ããšãŒãã®èªçºæ²æŸ±ã«é¢ã
ãŠã¯é飜åã§ãããèªç¶çºçæ²æŸ±ã«å¯ŸããŠã¯æºå®
å®ãªã«ã«ã·ãŠã ïŒãã¹ããšãŒã溶液ã«æ·»å ããã
ãã®çš®çµæ¶ã«ãããæ²æŸ±ããã³çµæ¶æé·ãèªçºã
ãããçš®æ¶æ·»å åã«ãè©ŠéšååŠç©è³ªãæºå®å®ãª
CaïŒïŒ°æº¶æ¶²ã«æ·»å ãããçš®çµæ¶ã«ããèªçºãã
ãããããã·ã¢ãã¿ã€ã圢æã«ã€ããŠã®ãããå
åŠç©è³ªã®å¹æã¯ãç³ç°åã«ã€ããŠã®ãããååŠç©
質ã®çäœå å¹æã瀺ããã®ã§ããããšãããã€
ãã ã«ã«ã·ãŠã ãã¹ããšãŒãçµæ¶ãçæãããšãæ°Ž
çŽ ã€ãªã³ã®æŸåºïŒPHå€åïŒãçãããçµæ¶æé·ã®
é床ã¯äžå®ãªPHãç¶æããã«å¿ èŠãªå¡©åºã®æ·»å ã
芳å¯ããããšã«ãã€ãŠç£èŠããããããªãã¹ãã
ãŒãã®äœãæ¿åºŠïŒïŒÃ10-6MïŒã§ã¯ãã«ã«ã·ãŠã
ãã¹ããšãŒãã®åœ¢æã20åé以äžé²æ¢ããããšã
å¯èœã§ãããçµæ¶æé·ã®é²æ¢ã¯ããªãã¹ãããŒã
ãã«ã«ã·ãŠã ãã¹ãããŒãçµæ¶æ žãžåžçããåŸå
ã«ãã€ãŠå·Šå³ããããCa3ïŒAPDïŒ2ã²ã«ããã®è©Š
éšã§APDã®ã¢ããããªãŠã å¡©ïŒå¯æº¶æ§ïŒãšæ¯èŒ
ãããã«ã«ã·ãŠã å¡©ïŒã²ã«ïŒã¯ããããã·ã¢ãã¿
ã€ãçµæ¶æé·ãé²æ¢ããã«ãããªãŠã å¡©ãšåãäœ
å¹æçã§ãã€ãã ã²ã«ã®çç©çåé 14CæšèïŒâã¢ããâïŒâããããã·ãããã³
âïŒïŒïŒâãžãã¹ãããŒãïŒ14CâAPDïŒã®ã«ã«
ã·ãŠã ããã³ãããªãŠã å¡©ãã©ããïŒã¹ãã¬ãŒ
ã°ã»ããŒãªãŒããã€ãŒã«ã¹ã»ãªããŒïŒã«ç®äžæäž
ããŠãããïŒçš®ã®åé ããã³ææ³ãæ¯èŒãããïŒ
mlãããAPDã2.85mgå«æããæäžéçŽ0.5ïœã®
溶液ãŸãã¯ã²ã«ãè¡é åäžã«æ³šå°ãããå矀ã®å
ç©æ°ã¯ïŒå¹ãšããã
ãè¡šã
åèšã®ããŒã¿ãããããåŸãããã«ãïŒçš®ã®æ
äžéã®æãéèŠãªå·®ã¯ãã«ã«ã·ãŠã å¡©ã²ã«ããã®
APDã®åŸæŸæ§ã§ãããšæãããããã®ãããæŸ
åºã®çµæãéåžžã«å°éã®ãžãã¹ãããŒããèèã«
ãã€ãŠåžåããããèå³æ·±ãããšã«ã¯ãå€§è ¿éªšïŒ
å šå°¿ã®æ¯ã¯äž¡è ã®å Žååäžã§ãããããªãã¡ã
APDã«ã«ã·ãŠã å¡©ã²ã«ã®éªšã«å¯Ÿãã芪ååã¯
APDãããªãŠã 塩溶液ã«ã€ããŠã®ãã®ãšåäžã§
ããããã®ããã«ãã«ã«ã·ãŠã å¡©ã®äžæº¶æ§ã®çµæ
ãšããŠå šèº«æŸåºãããããããšã骚ã«åãå ¥ããª
ããèèã«ããåžåçãæžå°ããããšã«ãªããšã
ãããšããã®ããŒã¿ã瀺ããŠããã è£åŒ·äœèªçºé¢ç¯çã©ããã¢ãã« ãã®åç©ã®ã¢ãã«ã«ãããŠãé±æ²¹ã«æžæ¿ããæ»
亡ãã³ãã¯ããªãŠã ã»ãããªã«ã ãã©ããã«æ³šå°
ããããšã«ãã€ãŠãã©ããã«é¢ç¯çãèªçºãã
ãããã®ã¢ãã«ã¯Calc.Tiss.Res.9å·»ã109ã121
è²¢ïŒ1972ïŒã«Francisçã«ãã€ãŠè©³çŽ°ã«èª¬æãã
ãŠããïŒãã®é瀺ãšæ¬çºæã§åç §ãããã®ãšã
ãïŒã äŸã«èšèŒã®ããã«èª¿è£œãããCa3ïŒAPDïŒ2ã®
0.5ïŒ ã²ã«ã§é¢ç¯ççåç©ãæ²»çãããã²ã«ã«ã
ãæ²»çã¯ãè©Šéšåç©ã®è¶³ã«éãççæ§ã®èšåŒµåå
å¿ãå§ãŸã€ãåŸãŸããªãéå§ãããå®éšèšç»ã以
äžã«æããã
äžéã®æãéèŠãªå·®ã¯ãã«ã«ã·ãŠã å¡©ã²ã«ããã®
APDã®åŸæŸæ§ã§ãããšæãããããã®ãããæŸ
åºã®çµæãéåžžã«å°éã®ãžãã¹ãããŒããèèã«
ãã€ãŠåžåããããèå³æ·±ãããšã«ã¯ãå€§è ¿éªšïŒ
å šå°¿ã®æ¯ã¯äž¡è ã®å Žååäžã§ãããããªãã¡ã
APDã«ã«ã·ãŠã å¡©ã²ã«ã®éªšã«å¯Ÿãã芪ååã¯
APDãããªãŠã 塩溶液ã«ã€ããŠã®ãã®ãšåäžã§
ããããã®ããã«ãã«ã«ã·ãŠã å¡©ã®äžæº¶æ§ã®çµæ
ãšããŠå šèº«æŸåºãããããããšã骚ã«åãå ¥ããª
ããèèã«ããåžåçãæžå°ããããšã«ãªããšã
ãããšããã®ããŒã¿ã瀺ããŠããã è£åŒ·äœèªçºé¢ç¯çã©ããã¢ãã« ãã®åç©ã®ã¢ãã«ã«ãããŠãé±æ²¹ã«æžæ¿ããæ»
亡ãã³ãã¯ããªãŠã ã»ãããªã«ã ãã©ããã«æ³šå°
ããããšã«ãã€ãŠãã©ããã«é¢ç¯çãèªçºãã
ãããã®ã¢ãã«ã¯Calc.Tiss.Res.9å·»ã109ã121
è²¢ïŒ1972ïŒã«Francisçã«ãã€ãŠè©³çŽ°ã«èª¬æãã
ãŠããïŒãã®é瀺ãšæ¬çºæã§åç §ãããã®ãšã
ãïŒã äŸã«èšèŒã®ããã«èª¿è£œãããCa3ïŒAPDïŒ2ã®
0.5ïŒ ã²ã«ã§é¢ç¯ççåç©ãæ²»çãããã²ã«ã«ã
ãæ²»çã¯ãè©Šéšåç©ã®è¶³ã«éãççæ§ã®èšåŒµåå
å¿ãå§ãŸã€ãåŸãŸããªãéå§ãããå®éšèšç»ã以
äžã«æããã
ãè¡šã
足ã®äœç©ã®å®é枬å®ã䜿çšããŠè£åŒ·äœããã³æ²»
çé€çæ³ã«å¯Ÿããççæ§é¢ç¯ã®åå¿ã枬å®ããã çµ æ APDã²ã«ã§ã¯ã巊足é¢ç¯ã§ã®é¢ç¯å ãŸãã¯ç®
äžïŒèåŸã§ã®ïŒã«ãããè£åŒ·äœæ³šå°ã«å¯Ÿããçç
æ§é¢ç¯åå¿ãèããæžå°ãããAPDã®é¢ç¯å 泚
å°ïŒå·Šè¶³ïŒã§ã¯ã巊足ã®ççã®æžå°ã¯ç®äžæ³šå°ã
ãèãã倧ããã¯çããªãã€ããããã¯APDã®
èããå±éšå¹æã¯å šããªãããšãæ瀺ããŠããã
å šèº«å¹æïŒå³è¶³èšåŒµåæžå°ïŒã¯ç®äžããã³é¢ç¯å
泚å°äž¡æ¹ãšãèããã€ãã äœéå¢å ã«ã€ããŠã¯ãèããã§ã¯ãªããããã®
å¹æããã€ããAPDæ²»çãè¡ãªã€ãåç©ã¯å¡©æ¶²
æ²»çããåç©ãããäœéãå¢ããããã¯ç æ°ã®å
ç©ã«èããå šäœã®å šèº«å©çã瀺ããŠããã éåžžã«äœãå šèº«æäžéïŒ0.06mgAPDïŒKgïŒã§ã
APDã«ã«ã·ãŠã å¡©ã¯é¢ç¯ççã©ããã«èããå š
身å©çããªãããå±éšå¹æããªããªãããšãçµæ
ã瀺ããŠãããäžèšã®ããŒã¿ããããžãããªãŠã
ãšãã¬ã³ããããã·ãžãã¹ãããŒãã®çŽ0.5ã1.0
mgïŒKgã®æäžéã§ã¯ãïŒæ¥ããšã«ã»ãŒçããå¹æ
ãåŸããããã²ã«ã¯è¬å€è²¯èµå¹æããããšæãã
ãã äŸ äžèšã«ç€ºããå 容ã®ã«ãã»ã«ãåŸæ¥æ¹æ³ã«ãã€
ãŠèª¿è£œããã æ å ïŒã«ãã»ã«ãããã®mg Ca3ïŒAPDïŒ2qel*ïŒ 17500.00 ãã³ãã³ 55.60 ã©ãŠãªã«ç¡«é žãããªãŠã 2.90* ïŒïŒïŒ Ca3ïŒAPDïŒ2ã98ïŒ æ°Ž äžèšã«ãã»ã«ãæ¥ã«ïŒåçµå£æäžãããšã骚å€
åçããããã€ãŠããäœéçŽ70Kgã®æ£è ã®éªšè±ç³
ç°åãå€§å¹ ã«æžå°ããã äŸ æ¬¡ã®çµæã®ç·Žãæ¯ç£šããåŸæ¥æ¹æ³ã«ãã€ãŠèª¿è£œ
ããã éééš Ca3ïŒAPDïŒ2ã²ã«* 33.08 ãœã«ãããŒã« 6.25 ãµãã«ãªã³ 0.12 ã«ã«ã·ãŠã ãããã¹ããšãŒã1 39.00 ã°ãªã»ãªã³ 18.00 ã¢ã«ãã«ïŒæ€°åïŒç¡«é žãããªãŠã 0.40 怰åã¢ãã°ãªã»ãªãã¹ã«ãã³é žãããªãŠã 0.75 ãããªãŠã ã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ 1.15 ãã°ãã·ãŠã ã¢ã«ãããŠã ã·ãªã±ãŒã 0.40 éŠ æ 0.85* ïŒïŒ Ca3ïŒAPDïŒ2ã98ïŒ æ°Ž ç±³åœç¹èš±ç¬¬3112247å·æ现æžïŒ1963幎11æïŒæ¥
亀ä»ïŒèšèŒã®æ¹æ³ã«ãã調補ãããã®ã ãã®çµæç©ã«ãããšãæ¯ã®ãšãã¡ã«è³ªäžã®çµç³
圢æã劚ããããã
çé€çæ³ã«å¯Ÿããççæ§é¢ç¯ã®åå¿ã枬å®ããã çµ æ APDã²ã«ã§ã¯ã巊足é¢ç¯ã§ã®é¢ç¯å ãŸãã¯ç®
äžïŒèåŸã§ã®ïŒã«ãããè£åŒ·äœæ³šå°ã«å¯Ÿããçç
æ§é¢ç¯åå¿ãèããæžå°ãããAPDã®é¢ç¯å 泚
å°ïŒå·Šè¶³ïŒã§ã¯ã巊足ã®ççã®æžå°ã¯ç®äžæ³šå°ã
ãèãã倧ããã¯çããªãã€ããããã¯APDã®
èããå±éšå¹æã¯å šããªãããšãæ瀺ããŠããã
å šèº«å¹æïŒå³è¶³èšåŒµåæžå°ïŒã¯ç®äžããã³é¢ç¯å
泚å°äž¡æ¹ãšãèããã€ãã äœéå¢å ã«ã€ããŠã¯ãèããã§ã¯ãªããããã®
å¹æããã€ããAPDæ²»çãè¡ãªã€ãåç©ã¯å¡©æ¶²
æ²»çããåç©ãããäœéãå¢ããããã¯ç æ°ã®å
ç©ã«èããå šäœã®å šèº«å©çã瀺ããŠããã éåžžã«äœãå šèº«æäžéïŒ0.06mgAPDïŒKgïŒã§ã
APDã«ã«ã·ãŠã å¡©ã¯é¢ç¯ççã©ããã«èããå š
身å©çããªãããå±éšå¹æããªããªãããšãçµæ
ã瀺ããŠãããäžèšã®ããŒã¿ããããžãããªãŠã
ãšãã¬ã³ããããã·ãžãã¹ãããŒãã®çŽ0.5ã1.0
mgïŒKgã®æäžéã§ã¯ãïŒæ¥ããšã«ã»ãŒçããå¹æ
ãåŸããããã²ã«ã¯è¬å€è²¯èµå¹æããããšæãã
ãã äŸ äžèšã«ç€ºããå 容ã®ã«ãã»ã«ãåŸæ¥æ¹æ³ã«ãã€
ãŠèª¿è£œããã æ å ïŒã«ãã»ã«ãããã®mg Ca3ïŒAPDïŒ2qel*ïŒ 17500.00 ãã³ãã³ 55.60 ã©ãŠãªã«ç¡«é žãããªãŠã 2.90* ïŒïŒïŒ Ca3ïŒAPDïŒ2ã98ïŒ æ°Ž äžèšã«ãã»ã«ãæ¥ã«ïŒåçµå£æäžãããšã骚å€
åçããããã€ãŠããäœéçŽ70Kgã®æ£è ã®éªšè±ç³
ç°åãå€§å¹ ã«æžå°ããã äŸ æ¬¡ã®çµæã®ç·Žãæ¯ç£šããåŸæ¥æ¹æ³ã«ãã€ãŠèª¿è£œ
ããã éééš Ca3ïŒAPDïŒ2ã²ã«* 33.08 ãœã«ãããŒã« 6.25 ãµãã«ãªã³ 0.12 ã«ã«ã·ãŠã ãããã¹ããšãŒã1 39.00 ã°ãªã»ãªã³ 18.00 ã¢ã«ãã«ïŒæ€°åïŒç¡«é žãããªãŠã 0.40 怰åã¢ãã°ãªã»ãªãã¹ã«ãã³é žãããªãŠã 0.75 ãããªãŠã ã«ã«ããã·ã¡ãã«ã»ã«ããŒã¹ 1.15 ãã°ãã·ãŠã ã¢ã«ãããŠã ã·ãªã±ãŒã 0.40 éŠ æ 0.85* ïŒïŒ Ca3ïŒAPDïŒ2ã98ïŒ æ°Ž ç±³åœç¹èš±ç¬¬3112247å·æ现æžïŒ1963幎11æïŒæ¥
亀ä»ïŒèšèŒã®æ¹æ³ã«ãã調補ãããã®ã ãã®çµæç©ã«ãããšãæ¯ã®ãšãã¡ã«è³ªäžã®çµç³
圢æã劚ããããã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ ããªã«ã«ã·ãŠã ãžïŒïŒâããããã·âïŒâã¢
ãããããã³âïŒïŒïŒâãžãã¹ãããŒãïŒãçŽ
0.01ïŒ ãïŒïŒ å«æããæ°Žæ§ã²ã«ã ïŒ ããªã«ã«ã·ãŠã ãžïŒïŒâããããã·âïŒâã¢
ãããããã³âïŒïŒïŒâãžãã¹ãããŒãïŒãçŽ
0.05ïŒ ãçŽïŒïŒ å«æãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
ã«èšèŒã®ã²ã«ã ïŒ ããªã«ã«ã·ãŠã ãžïŒïŒâããããã·âïŒâã¢
ãããããã³âïŒïŒïŒâãžãã¹ãããŒãïŒçŽ0.01
mgãçŽ40ïœããã³è¬å€çšæ äœãããªããåèšãžã
ã¹ãããŒãã¯æ°Žæ§ã²ã«ç¶ã§ãããåäœæè¬åœ¢æ ã®
è¬å€çµæç©ã ïŒ ããªã«ã«ã·ãŠã ãžïŒïŒâããããã·âïŒâã¢
ãããããã³âïŒïŒïŒâãžãã¹ãããŒãïŒã®éã
çŽ0.1mgãçŽ750mgã§ãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé
ã«èšèŒã®çµæç©ã ïŒ ããªã«ã«ã·ãŠã ãžïŒïŒâããããã·âïŒâã¢
ãããããã³âïŒïŒïŒâãžãã¹ãããŒãïŒçŽ10mg
ãçŽ20ïœãå«æãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ã«èš
èŒã®çµå£æäžçšã®çµæç©ã ïŒ ããªã«ã«ã·ãŠã ãžïŒïŒâããããã·âïŒâã¢
ãããããã³âïŒïŒïŒâãžãã¹ãããŒãïŒãçŽ
0.01ïŒ ãçŽïŒïŒ å«æããæ°Žæ§ã²ã«çŽïŒïŒ ãçŽ99ïŒ
ãå«æããŠãªããç·Žãæ¯ç£šãã ïŒ éªšã®ä»£è¬çŸæ£ããããã€ãŠããäœçŽæž©è¡åç©
ã«ãããªã«ã«ã·ãŠã ãžïŒïŒâããããã·âïŒâã¢
ãããããã³âïŒïŒïŒâãžãã¹ãããŒãïŒãçŽ
0.01ïŒ ãçŽïŒïŒ å«æããã²ã«ãå®å šãã€å¹æçãª
éå šèº«æäžããããšãããªãã骚ã®ä»£è¬çŸæ£ãæ²»
çããæ¹æ³ã ïŒ é¢ç¯çããããã€ãŠããäœçŽæž©è¡åç©ã«ãã
ãªã«ã«ã·ãŠã ãžïŒïŒâããããã·âïŒâã¢ããã
ããã³âïŒïŒïŒâãžãã¹ãããŒãïŒãçŽ0.01ïŒ ã
çŽïŒïŒ å«æããã²ã«ãå®å šãã€å¹æçãªéå šèº«æ
äžããããšãããªããé¢ç¯çãæ²»çããæ¹æ³ã ïŒ ç®èçµç¹ã®ç³ç°åãçããŠããéšäœã«ãããª
ã«ã«ã·ãŠã ãžïŒïŒâããããã·âïŒâã¢ãããã
ãã³âïŒïŒïŒâãžãã¹ãããŒãïŒãçŽ0.01ïŒ ãçŽ
ïŒïŒ å«æããã²ã«ãå®å šãã€å¹æçãªéé©çšãã
ããšãããªããç®èçµç¹ã®ç³ç°åãæ²»çãŸãã¯äº
é²ããæ¹æ³ã ïŒïŒ ããªã«ã«ã·ãŠã ãžïŒïŒâããããã·âïŒâ
ã¢ãããããã³âïŒïŒïŒâãžãã¹ãããŒãïŒãçŽ
0.01ïŒ ãçŽïŒïŒ å«æããã²ã«ãå®å šãã€å¹æçãª
éé©çšããããšãããªããæ¯ç³ãæ²»çãŸãã¯äºé²
ããæ¹æ³ã
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/379,234 US4446052A (en) | 1982-05-17 | 1982-05-17 | Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate |
| US379234 | 1999-08-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5931789A JPS5931789A (ja) | 1984-02-20 |
| JPH0415235B2 true JPH0415235B2 (ja) | 1992-03-17 |
Family
ID=23496387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP58085143A Granted JPS5931789A (ja) | 1982-05-17 | 1983-05-17 | ïŒâããããã·âïŒâã¢ãããããã³âïŒïŒïŒâãžãã¹ãã³é žã®ã²ã«æ§ã«ã«ã·ãŠã å¡© |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US4446052A (ja) |
| EP (1) | EP0094714A3 (ja) |
| JP (1) | JPS5931789A (ja) |
| CA (1) | CA1202239A (ja) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4639338A (en) * | 1984-08-06 | 1987-01-27 | Ciba-Geigy Corporation | Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate |
| IT1187828B (it) * | 1985-05-24 | 1987-12-23 | Gentili Ist Spa | Composizione farmaceutica a base di difosfonati per il trattamento dell aretrosi |
| US4877603A (en) * | 1987-12-18 | 1989-10-31 | The Procter & Gamble Company | Oral compositions |
| MX21453A (es) * | 1989-07-07 | 1994-01-31 | Ciba Geigy Ag | Preparaciones farmaceuticas que se administran en forma topica. |
| CA2035179C (en) * | 1990-01-31 | 2001-08-14 | Gerald S. Brenner | Pharmaceutical compositions containing insoluble salts of bisphosphonic acids |
| US5356887A (en) * | 1990-01-31 | 1994-10-18 | Merck & Co., Inc. | Pharmaceutical compositions containing insoluble calcium salts of amino-hydroxybutylidene bisphoshonic acids |
| US5270365A (en) * | 1991-12-17 | 1993-12-14 | Merck & Co., Inc. | Prevention and treatment of periodontal disease with alendronate |
| US5646134A (en) * | 1994-04-21 | 1997-07-08 | Merck & Co., Inc. | Alendronate therapy to prevent loosening of, or pain associated with, orthopedic implant devices |
| KR100343232B1 (ko) * | 1999-12-10 | 2002-07-10 | ê¹ì¬ì€ | ê²°ì ì± í믞ëë¡ ì° ìŽëížë¥šìŒ ìí묌곌 ê·žì ì ì¡°ë°©ë² |
| KR100492110B1 (ko) * | 2000-05-05 | 2005-06-02 | ìí. ížíë§-ëŒ ë¡ì ìê² | ë¹ì€í¬ì€í°ì° ëë ê·žì ìŒì í¬íšíë íŒí í¬ì¬ì©ê²-ì ì¬ ìœí ì¡°ì±ë¬Œ |
| WO2002058708A1 (en) * | 2001-01-23 | 2002-08-01 | Gador S.A. | Composition comprising bisphosphonates for prevention and/or treatment of metabolic diseases of bones, process for preparing such composition and use thereof |
| US8882740B2 (en) | 2009-12-23 | 2014-11-11 | Stryker Trauma Gmbh | Method of delivering a biphosphonate and/or strontium ranelate below the surface of a bone |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3101301A (en) * | 1962-05-11 | 1963-08-20 | Bristol Myers Co | Transparent water and mineral oil gels as hair conditioners |
| US3608067A (en) * | 1968-03-08 | 1971-09-21 | Monsanto Co | Dentifrice compositions containing insoluble salts of alkylene phosphonic acids |
| US3683080A (en) * | 1970-08-28 | 1972-08-08 | Procter & Gamble | Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue |
| DE2405254C2 (de) * | 1974-02-04 | 1982-05-27 | Henkel KGaA, 4000 DÃŒsseldorf | Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsÀure oder ihrer wasserlöslichen Salze bei der BeeinfluÃung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper |
| DE2534391C2 (de) * | 1975-08-01 | 1983-01-13 | Henkel KGaA, 4000 DÌsseldorf | 1-Hydroxy-3-aminoalkan-1,1-diphosphonsÀuren |
| US4200539A (en) * | 1978-04-20 | 1980-04-29 | Halliburton Company | Fracturing compositions and method of preparing and using the same |
| DE2943498C2 (de) * | 1979-10-27 | 1983-01-27 | Henkel KGaA, 4000 DÌsseldorf | Verfahren zur Herstellung von 3-Amino-1-hydroxypropan-1,1-diphosphonsÀure |
-
1982
- 1982-05-17 US US06/379,234 patent/US4446052A/en not_active Expired - Lifetime
-
1983
- 1983-05-06 EP EP83200658A patent/EP0094714A3/en not_active Withdrawn
- 1983-05-16 CA CA000428203A patent/CA1202239A/en not_active Expired
- 1983-05-17 JP JP58085143A patent/JPS5931789A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| US4446052A (en) | 1984-05-01 |
| JPS5931789A (ja) | 1984-02-20 |
| CA1202239A (en) | 1986-03-25 |
| EP0094714A3 (en) | 1984-02-29 |
| EP0094714A2 (en) | 1983-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3706792B2 (ja) | å±æçšäºéçµæç©ããã³äœ¿çšæ¹æ³ | |
| CA1174602A (en) | Pharmaceutical composition for the treatment of osteopathias | |
| JPH0415235B2 (ja) | ||
| US4086334A (en) | Composition and method for the treatment of disorders of calcium metabolism | |
| US4269828A (en) | Indole anti-inflammatory composition | |
| US4634691A (en) | Method for inhibiting tumor metastasis | |
| BRPI0707008A2 (pt) | associação em doses fixas de fitato e zinco | |
| EP1605955B1 (en) | Anti-inflammatory composition based on strontium compounds | |
| NL8004904A (nl) | Geneesmiddel tegen resorptie van botmineraal. | |
| US4264582A (en) | Isobutylphenylacetate anti-inflammatory composition | |
| US4282214A (en) | Phenylacetate anti-inflammatory composition | |
| US4216212A (en) | Pyrazolidine anti-inflammatory composition and methods of use | |
| JP3796693B2 (ja) | ãªã«ãããããŒããããªã骚å¡ååçµæç© | |
| CA1337928C (en) | Topically applied gold organic complex | |
| US5348749A (en) | Method for treating panic disorder | |
| MX2013010622A (es) | Composiciones y métodos para el tratamiento de enfermedades y transtornos relacionados con el tejido musculoesquelético utilizando complejos de análogo de citrato de ion metálico. | |
| US5527779A (en) | Topically applied gold organic complex | |
| Watt et al. | Effects of acute administration of ethane hydroxydiphosphonate (EHDP) on skeletal scintigraphy with technetium-99m methylene diphosphonic acid (Tc-MDP) in the rat | |
| US3842169A (en) | Composition and method for treatment of pathological calcification in animals | |
| KR860000514B1 (ko) | íë ííë ìžì ìì©ì¡ì ì ì¡°ë°©ë² | |
| US3703579A (en) | Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue | |
| DK164443B (da) | Anvendelse af en peroxydiphosphatforbindelse til fremstilling af et laegemiddel til haemning af parathyreoideahormoninduceret knogleresorption | |
| IE47042B1 (en) | Anti-inflammatory drug based on phosphonates plus other anti-inflammatories | |
| JPH0680570A (ja) | 骚代è¬æ¹åå€ | |
| JPS5834445B2 (ja) | çµå£æµå°¿çµç³çå€ |